×

Browse

Abstracts

01
Nov

Assessment of Efficacy of Omalizumab Retreatment in Patients With Severe Asthma
Respiratory
Omalizumab is a recombinant humanised monoclonal anti-IgE antibody currently approved in the USA and Europe for treating inadequately controlled allergic…
01
Nov

Polymetallic Dust-Induced Pneumoconiosis: An Experimental Study
Respiratory
Dust load and oxidative stress play a leading role in the development of pneumoconiosis. The aim of this study was to examine the role of macrophages and…
01
Nov

Daily Physical Activity in Patients with Severe Eosinophilic Asthma and the Effect of Anti-IL-5 Therapy
Respiratory
Severe asthma, with an estimated prevalence of 5–10% in the total asthma population, impacts considerably on morbidity, mortality, and socioeconomic cost…
01
Nov

A Simple Multifunctional Tool for Integrated Care for Chronic Obstructive Pulmonary Disease
Respiratory
National and European initiatives to drive quality improvement in chronic obstructive pulmonary disease (COPD)1,2 have led to integrated care models…
01
Nov

A Multidimensional Approach to Chronic Obstructive Pulmonary Disease Comorbidities
Respiratory
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is predicted to be the third leading cause of death by…
01
Nov

Does Talc Increase Risk of Subsequent Non-Draining Septated Pleural Effusion after Indwelling Pleural Catheter Insertion?
Respiratory
Current management of recurrent pleural effusion is symptomatic. Indwelling pleural catheters (IPC) reduce the initial length of hospital stay…
01
Nov

Pneumothorax Induction with a Boutin Needle without Ultrasound Guidance During Local Anaesthetic Thoracoscopy
Respiratory
Pleural disease is an increasingly common presentation and it has been estimated that up to 15% of patients have a metastatic pleural effusion at…
01
Nov

Innovating the Treatment of Chronic Obstructive Pulmonary Disease Exacerbations: A Phone Telesystem to Increase Action Plan Adherence
Respiratory
Chronic obstructive pulmonary disease (COPD) exacerbations are major contributors to the burden of the disease, reducing patients’ quality of life…